BTCY Stock Price, Chart, Stats & News
Biotricity, Inc. (BTCY) does not currently pay a dividend.
BTCY chart
Fundamentals
Gross margin | 81.09% |
Operating margin | 0.91% |
Pretax margin | -25.99% |
Net margin | -25.99% |
Effective tax rate | – |
ROA | -70.62% |
ROE | 12.85% |
D/E | -0.83x |
Interest coverage ratio | 0.04x |
BTCY valuation
P/E | – |
P/S | 0.49x |
P/B | -0.22x |
P/CF | -6.65x |
P/FCF | -6.86x |
P/OCF | -6.65x |
PEG | -0.18x |
EV multiple | -72.13x |
About
Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.
Similar securities
Based on sector and market capitalization
